Stelara (ustekinumab) is a prescription injection that’s used to treat certain autoimmune conditions, such as plaque psoriasis. Stelara can cause side effects that range from mild to serious.

Before 2023, Medicare Part B covered subcutaneous versions of Stelara, which a physician had to inject into someone’s skin. However, Medicare Administrative Contractors now consider Stelara a ...

The companies said the FDA approved a 130mg/26mL single dose vial of the product for intravenous infusion, which should ...

Cigna's (NYSE:CI) pharmacy benefit manager, Evernorth Health Services, announced on Thursday plans to launch a biosimilar to ...